| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| [2] |
郑舒月，李伦，吴炅. 乳腺癌术后乳房重建手术的患者报告结局研究进展 [J/CD]. 中华乳腺病杂志(电子版), 2021，15(5): 311-314.
|
| [3] |
Fleming MM, Holbrook AI, Newell MS. Update on image-guided percutaneous ablation of breast cancer [J]. AJR Am J Roentgenol, 2017, 208(2): 267-274.
|
| [4] |
Geboers B, Scheffer HJ, Graybill PM, et al. High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy [J]. Radiology, 2020, 295(2): 254-272.
|
| [5] |
Aguilar AA, Ho MC, Chang E, et al. Permeabilizing cell membranes with electric fields [J]. Cancers (Basel), 2021, 13(9): 2283.
|
| [6] |
Aslam MA, Riaz K, Mahmood MQ, et al. Hybrid analytical-numerical approach for investigation of differential effects in normal and cancer cells under electroporation [J]. Rsc Adv, 2019, 9(71): 41518-41530.
|
| [7] |
Probst U, Fuhrmann I, Beyer L, et al. Electrochemotherapy as a new modality in interventional oncology: a review [J]. Technol Cancer Res Treat, 2018, 17: 1533033818785329.
|
| [8] |
Cadossi R, Ronchetti M, Cadossi M. Locally enhanced chemotherapy by electroporation: clinical experiences and perspective of use of electrochemotherapy [J]. Future Oncol, 2014, 10(5): 877-890.
|
| [9] |
Riaz K, Leung SF, Fan Z, et al. Low-cost energy-efficient 3-D nano-spikes-based electric cell lysis chips [J]. J Microelectromech S, 2017, 26(4): 910-920.
|
| [10] |
Neal RE, Singh R, Hatcher HC, et al. Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode [J]. Breast Cancer Res Treat, 2010, 123(1): 295-301.
|
| [11] |
Chen Y, Moser MAJ, Luo Y, et al. Chemical enhancement of irreversible electroporation: a review and future suggestions [J]. Technol Cancer Res Treat, 2019, 18: 1533033819874128.
|
| [12] |
Poompavai S, Sree VG, Priyaa AK. Electrothermal analysis of the breast-tumor model during electroporation [J]. IEEE T Radiat Plasma, 2020, 4(4): 512-524.
|
| [13] |
Habrawi Z, Melkus MW, Khan S, et al. Cryoablation: a promising non-operative therapy for low-risk breast cancer [J]. Am J Surg, 2021, 221(1): 127-133.
|
| [14] |
Bulvik BE, Rozenblum N, Gourevich S, et al. Irreversible electroporation versus radiofrequency ablation: a comparison of local and systemic effects in a small-animal model [J]. Radiology, 2016, 280(2): 413-424.
|
| [15] |
Galluzzi L, Buqué A, Kepp O, et al. Immunogenic cell death in cancer and infectious disease [J]. Nat Rev Immunol, 2017, 17(2): 97-111.
|
| [16] |
Goswami I, Coutermarsh-Ott S, Morrison RG, et al. Irreversible electroporation inhibits pro-cancer inflammatory signaling in triple negative breast cancer cells [J]. Bioelectrochemistry, 2017, 113: 42-50.
|
| [17] |
Guo S, Jing Y, Burcus NI, et al. Nano-pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases [J]. Int J Cancer, 2018, 142(3): 629-640.
|
| [18] |
Ringel-Scaia VM, Beitel-White N, Lorenzo MF, et al. High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity [J]. EBioMedicine, 2019, 44: 112-125.
|
| [19] |
Babikr F, Wan J, Xu A, et al. Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors [J]. Cell Mol Immunol, 2021, 18(12): 2632-2647.
|
| [20] |
徐芸，张海燕，蒋春燕，等. 乳腺癌术后化疗患者支持性照顾需求、心理弹性及生活质量的相关性 [J/CD]. 中华乳腺病杂志(电子版), 2021, 15(6): 352-358.
|
| [21] |
Łapińska Z, Saczko J. Novel electroporation-based treatments for breast cancer [J]. Adv Clin Exp Med, 2022, 31(11): 1183-1186.
|
| [22] |
Rodrigues PG, Miranda-Silva D, Costa SM, et al. Early myocardial changes induced by doxorubicin in the nonfailing dilated ventricle [J]. Am J Physiol Heart Circ Physiol, 2019, 316(3): H459-H475.
|
| [23] |
Rembialkowska N, Dubinska-Magiera M, Sikora A, et al. Doxorubicin assisted by microsecond electroporation promotes irreparable morphological alternations in sensitive and resistant human breast adenocarcinoma cells [J]. Appl Sci Basel, 2020, 10(8): 2765.
|
| [24] |
Batista Napotnik T, Miklavčič D. In vitro electroporation detection methods-an overview [J]. Bioelectrochemistry, 2018, 120: 166-182.
|
| [25] |
Ruzgys P, Navickaitė D, Palepšienė R, et al. Induction of bystander and abscopal effects after electroporation-based treatments [J]. Cancers (Basel), 2022, 14(15): 3770.
|
| [26] |
管晓翔，谢晖. 三阴性乳腺癌含铂方案临床应用专家共识(2021版) [J]. 中华肿瘤防治杂志，2021, 28(12): 885-890.
|
| [27] |
Mittal L, Aryal UK, Camarillo IG, et al. Quantitative proteomic analysis of enhanced cellular effects of electrochemotherapy with cisplatin in triple-negative breast cancer cells [J]. Sci Rep, 2019, 9(1): 13916.
|
| [28] |
Mittal L, Raman V, Camarillo IG, et al. Ultra-microsecond pulsed curcumin for effective treatment of triple negative breast cancers [J]. Biochem Biophys Res Commun, 2017, 491(4): 1015-1020.
|
| [29] |
Mittal L, Raman V, Camarillo IG, et al. Viability and cell cycle studies of metastatic triple negative breast cancer cells using low voltage electrical pulses and herbal curcumin [J]. Biomed Phys Eng Expr, 2019, 5(2): 025040.
|
| [30] |
Lu CH, Lin SH, Hsieh CH, et al. Enhanced anticancer effects of low-dose curcumin with non-invasive pulsed electric field on PANC-1 cells [J]. Onco Targets Ther, 2018, 11: 4723-4732.
|
| [31] |
Mittal L, Aryal UK, Camarillo IG, et al. Effective electrochemotherapy with curcumin in MDA-MB-231-human, triple negative breast cancer cells: a global proteomics study [J]. Bioelectrochemistry, 2020, 131: 107350.
|
| [32] |
Romeo S, Sannino A, Scarfì MR, et al. ESOPE-equivalent pulsing protocols for calcium electroporation: an in vitro optimization study on 2 cancer cell models [J]. Technol Cancer Res Treat, 2018, 17: 1533033818788072.
|
| [33] |
Frandsen SK, Vissing M, Gehl J. A comprehensive review of calcium electroporation-a novel cancer treatment modality [J]. Cancers (Basel), 2020, 12(2): 290.
|
| [34] |
Gibot L, Montigny A, Baaziz H, et al. Calcium delivery by electroporation induces in vitro cell death through mitochondrial dysfunction without DNA damages [J]. Cancers (Basel), 2020, 12(2): 425.
|
| [35] |
Frandsen SK, Gissel H, Hojman P, et al. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis [J]. Cancer Res, 2012, 72(6): 1336-1341.
|
| [36] |
Kulbacka J, Rembiałkowska N, Szewczyk A, et al. The impact of extracellular Ca(2＋) and nanosecond electric pulses on sensitive and drug-resistant human breast and colon cancer cells [J]. Cancers (Basel), 2021, 13(13): 3216.
|
| [37] |
Falk H, Forde PF, Bay ML, et al. Calcium electroporation induces tumor eradication, long-lasting immunity and cytokine responses in the CT26 colon cancer mouse model [J]. Oncoimmunology, 2017, 6(5): e1301332.
|
| [38] |
Łapińska Z, Dębiński M, Szewczyk A, et al. Electrochemotherapy with calcium chloride and 17β-estradiol modulated viability and apoptosis pathway in human ovarian cancer [J]. Pharmaceutics, 2020, 13(1): 19.
|
| [39] |
Frandsen SK, Gehl J. Effect of calcium electroporation in combination with metformin in vivo and correlation between viability and intracellular ATP level after calcium electroporation in vitro [J]. PLoS One, 2017, 12(7): e0181839.
|
| [40] |
Bazzolo B, Mittal L, Sieni E, et al. The electrical pulse application enhances intra-cellular localization and potentiates cytotoxicity of curcumin in breast cancer cells [J]. Bioelectrochemistry, 2021, 140: 107817.
|
| [41] |
Radica MK, Fabbri N, Santandrea G, et al. Use of electrochemotherapy in a voluminous chest wall recurrence of triple-negative breast cancer: case report [J]. AME Case Rep, 2020, 4: 30.
|
| [42] |
Russano F, Del Fiore P, Di Prata C, et al. The role of electrochemotherapy in the cutaneous and subcutaneous metastases from breast cancer: analysis of predictive factors to treatment from an italian cohort of patients [J]. Front Oncol, 2021, 11: 772144.
|
| [43] |
Campana LG, Galuppo S, Valpione S, et al. Bleomycin electrochemotherapy in elderly metastatic breast cancer patients: clinical outcome and management considerations [J]. J Cancer Res Clin Oncol, 2014, 140(9): 1557-1565.
|
| [44] |
Grischke EM, Rohm C, Stauss E, et al. Electrochemotherapy-supplementary treatment for loco-regional metastasized breast carcinoma administered to concomitant systemic therapy [J]. Radiol Oncol, 2017, 51(3): 317-323.
|
| [45] |
Sersa G, Cufer T, Paulin SM, et al. Electrochemotherapy of chest wall breast cancer recurrence [J]. Cancer Treat Rev, 2012, 38(5): 379-386.
|
| [46] |
Matthiessen LW, Kamby C, Hendel HW, et al. Electrochemotherapy as palliative treatment for chest wall recurrence of breast cancer-initial results [J]. EJC Suppl, 2009, 7(2): 273.
|
| [47] |
Matthiessen LW, Keshtgar M, Curatolo P, et al. Electrochemotherapy for breast cancer-results from the INSPECT database [J]. Clin Breast Cancer, 2018, 18(5): e909-e917.
|